Daniel W. Chan

No ORCID on file · 4 papers in corpus
other 2020
Cell reports ·doi:10.1016/j.celrep.2020.108276

Many gene products exhibit great structural heterogeneity because of an array of modifications. These modifications are not directly encoded in the genomic template but often affect the functionality of proteins. Protein glycosylation plays…

review 2009
Expert opinion on medical diagnostics ·doi:10.1517/17530050903266830

BACKGROUND: Plasma tumor biomarkers are widely used clinically for monitoring response to therapy and detecting cancer recurrence. However, only a limited number of them have been effectively used for the early detection of cancer. OBJECTIV…

diagnostic-accuracy 2007
Gynecologic Oncology ·doi:10.1016/j.ygyno.2007.08.009

OBJECTIVE: Currently available tumor markers for ovarian cancer are still inadequate in both sensitivity and specificity to be used for population-based screening. Artificial neural network (ANN) as a modeling tool has demonstrated its abil…

2004

Early detection remains the most promising approach to improve long-term survival of patients with ovarian cancer. In a five-center case-control study, serum proteomic expressions were analyzed on 153 patients with invasive epithelial ovari…